Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,226.40
(
0.39%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
102.20
(
1.54%
)
Bitcoin
72,807.54
(
-1.53%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 34934

Tuesday, 12/19/2006 8:47:26 AM

Tuesday, December 19, 2006 8:47:26 AM

Post# of 257253
HGSI initiates phase-3 Albuferon trial in genotype-1 HCV. The companion phase-3 trial in genotype-2 and genotype-3 is slated to start in 1H07 (which probably means 2Q07).

http://biz.yahoo.com/prnews/061219/nytu060.html?.v=78

Please see #msg-13781766 for a description of the phase-3 Albuferon program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now